11-19-2018 – ETBI – EastGate Biotech Appoints World-Renowned Diabetes Key Opinion Leader Dr. Lalit Upadhyay for Upcoming Initiatives
Key Opinion Leader spreading awareness of diabetes endorses the company's liquid insulin mouth rinse solution for Type 2 diabetes and pre-diabetes patients WEST CALDWELL, NJ and TORONTO, ON / ACCESSWIRE / November 19, 2018 / EastGate Biotech Corp. (OTC PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of type 2 diabetes, appointed key advisor Dr. Lalit Upadhyay to be the diabetes ambassador to help drive awareness of the company's liquid insulin mouth rinse solution for Type 2 diabetes and pre-diabetes patients. Dr. Lalit has devoted his life messaging that managing...
